Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug users

Dawn A. Fishbein, Yungtai Lo, Dale Netski, David L. Thomas, Robert S. Klein

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

High levels of hepatitis C virus (HCV) RNA are associated with a poor response to treatment of chronic hepatitis C, and a substantial reduction in HCV RNA levels predicts a favorable treatment response. We prospectively studied time-dependent and time-independent predictors of HCV RNA levels in 264 drug users with chronic HCV infection. Interviews on medical history and high-risk behaviors, phlebotomy for HIV viral load, serum HCV RNA levels as measured by the COBAS Amplicor HCV Monitor (Roche Diagnostics, Branchburg, NJ), and a lymphocyte subset assay were performed. Factors associated with HCV RNA levels over time were analyzed using a linear mixed model. Nearly 70% of the participants were men, two thirds were Hispanic, and the mean age was 46 years. HCV RNA levels increased over time. Older age (P < 0.001), HIV seropositivity (P = 0.03), and HCV nongenotype 1 (P = 0.05) were predictors of higher HCV RNA levels on multivariate analysis. Among 142 HIV-seropositive participants, a detectable HIV-1 viral load (P < 0.001) and recent alcohol use (P = 0.02) were predictors of higher HCV RNA levels. The predictors of higher HCV RNA levels found in this longitudinal study are consistent with those of prior cross-sectional studies. Further studies are warranted to determine if treatment of alcohol use affects HCV RNA levels.

Original languageEnglish (US)
Pages (from-to)471-476
Number of pages6
JournalJournal of Acquired Immune Deficiency Syndromes
Volume41
Issue number4
DOIs
StatePublished - Apr 2006

Fingerprint

Drug Users
Hepacivirus
Cohort Studies
Prospective Studies
RNA
Chronic Hepatitis C
Viral Load
Alcohols
HIV
HIV Seropositivity
Phlebotomy
Lymphocyte Subsets
Virus Diseases
Risk-Taking
Hispanic Americans
Longitudinal Studies
HIV-1
Linear Models
Therapeutics
Multivariate Analysis

Keywords

  • Drug users
  • Hepatitis C
  • Hepatitis C RNA
  • Hepatitis C virus RNA levels
  • HIV-hepatitic C virus coinfection

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this

Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug users. / Fishbein, Dawn A.; Lo, Yungtai; Netski, Dale; Thomas, David L.; Klein, Robert S.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 41, No. 4, 04.2006, p. 471-476.

Research output: Contribution to journalArticle

Fishbein, Dawn A. ; Lo, Yungtai ; Netski, Dale ; Thomas, David L. ; Klein, Robert S. / Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug users. In: Journal of Acquired Immune Deficiency Syndromes. 2006 ; Vol. 41, No. 4. pp. 471-476.
@article{6a0017b238204f848127ff6a558f3d20,
title = "Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug users",
abstract = "High levels of hepatitis C virus (HCV) RNA are associated with a poor response to treatment of chronic hepatitis C, and a substantial reduction in HCV RNA levels predicts a favorable treatment response. We prospectively studied time-dependent and time-independent predictors of HCV RNA levels in 264 drug users with chronic HCV infection. Interviews on medical history and high-risk behaviors, phlebotomy for HIV viral load, serum HCV RNA levels as measured by the COBAS Amplicor HCV Monitor (Roche Diagnostics, Branchburg, NJ), and a lymphocyte subset assay were performed. Factors associated with HCV RNA levels over time were analyzed using a linear mixed model. Nearly 70{\%} of the participants were men, two thirds were Hispanic, and the mean age was 46 years. HCV RNA levels increased over time. Older age (P < 0.001), HIV seropositivity (P = 0.03), and HCV nongenotype 1 (P = 0.05) were predictors of higher HCV RNA levels on multivariate analysis. Among 142 HIV-seropositive participants, a detectable HIV-1 viral load (P < 0.001) and recent alcohol use (P = 0.02) were predictors of higher HCV RNA levels. The predictors of higher HCV RNA levels found in this longitudinal study are consistent with those of prior cross-sectional studies. Further studies are warranted to determine if treatment of alcohol use affects HCV RNA levels.",
keywords = "Drug users, Hepatitis C, Hepatitis C RNA, Hepatitis C virus RNA levels, HIV-hepatitic C virus coinfection",
author = "Fishbein, {Dawn A.} and Yungtai Lo and Dale Netski and Thomas, {David L.} and Klein, {Robert S.}",
year = "2006",
month = "4",
doi = "10.1097/01.qai.0000218360.28712.f3",
language = "English (US)",
volume = "41",
pages = "471--476",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug users

AU - Fishbein, Dawn A.

AU - Lo, Yungtai

AU - Netski, Dale

AU - Thomas, David L.

AU - Klein, Robert S.

PY - 2006/4

Y1 - 2006/4

N2 - High levels of hepatitis C virus (HCV) RNA are associated with a poor response to treatment of chronic hepatitis C, and a substantial reduction in HCV RNA levels predicts a favorable treatment response. We prospectively studied time-dependent and time-independent predictors of HCV RNA levels in 264 drug users with chronic HCV infection. Interviews on medical history and high-risk behaviors, phlebotomy for HIV viral load, serum HCV RNA levels as measured by the COBAS Amplicor HCV Monitor (Roche Diagnostics, Branchburg, NJ), and a lymphocyte subset assay were performed. Factors associated with HCV RNA levels over time were analyzed using a linear mixed model. Nearly 70% of the participants were men, two thirds were Hispanic, and the mean age was 46 years. HCV RNA levels increased over time. Older age (P < 0.001), HIV seropositivity (P = 0.03), and HCV nongenotype 1 (P = 0.05) were predictors of higher HCV RNA levels on multivariate analysis. Among 142 HIV-seropositive participants, a detectable HIV-1 viral load (P < 0.001) and recent alcohol use (P = 0.02) were predictors of higher HCV RNA levels. The predictors of higher HCV RNA levels found in this longitudinal study are consistent with those of prior cross-sectional studies. Further studies are warranted to determine if treatment of alcohol use affects HCV RNA levels.

AB - High levels of hepatitis C virus (HCV) RNA are associated with a poor response to treatment of chronic hepatitis C, and a substantial reduction in HCV RNA levels predicts a favorable treatment response. We prospectively studied time-dependent and time-independent predictors of HCV RNA levels in 264 drug users with chronic HCV infection. Interviews on medical history and high-risk behaviors, phlebotomy for HIV viral load, serum HCV RNA levels as measured by the COBAS Amplicor HCV Monitor (Roche Diagnostics, Branchburg, NJ), and a lymphocyte subset assay were performed. Factors associated with HCV RNA levels over time were analyzed using a linear mixed model. Nearly 70% of the participants were men, two thirds were Hispanic, and the mean age was 46 years. HCV RNA levels increased over time. Older age (P < 0.001), HIV seropositivity (P = 0.03), and HCV nongenotype 1 (P = 0.05) were predictors of higher HCV RNA levels on multivariate analysis. Among 142 HIV-seropositive participants, a detectable HIV-1 viral load (P < 0.001) and recent alcohol use (P = 0.02) were predictors of higher HCV RNA levels. The predictors of higher HCV RNA levels found in this longitudinal study are consistent with those of prior cross-sectional studies. Further studies are warranted to determine if treatment of alcohol use affects HCV RNA levels.

KW - Drug users

KW - Hepatitis C

KW - Hepatitis C RNA

KW - Hepatitis C virus RNA levels

KW - HIV-hepatitic C virus coinfection

UR - http://www.scopus.com/inward/record.url?scp=33646784008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646784008&partnerID=8YFLogxK

U2 - 10.1097/01.qai.0000218360.28712.f3

DO - 10.1097/01.qai.0000218360.28712.f3

M3 - Article

C2 - 16652056

AN - SCOPUS:33646784008

VL - 41

SP - 471

EP - 476

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 4

ER -